Cwm, LLC Oncocyte Corp Transaction History

Cwm, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$0.86 - $1.53 $86 - $153	-100 Closed	0 $0
Q2 2020 Sep 15, 2021	SELL	$1.91 - $3.45 $1,929 - $3,484	-1,010 Reduced 90.99%	100 $1,000
Q2 2020 Jul 22, 2020	BUY	$1.91 - $3.45 $1,929 - $3,484	1,010 Added 1010.0%	1,110 $2,000
Q1 2020 Sep 15, 2021	SELL	$1.76 - $3.02 $1,777 - $3,050	-1,010 Reduced 90.99%	100 $1,000
Q1 2020 Apr 28, 2020	BUY	$1.76 - $3.02 $1,777 - $3,050	1,010 Added 1010.0%	1,110 $3,000
Q4 2019 Sep 14, 2021	SELL	$1.51 - $2.27 $1,374 - $2,065	-910 Reduced 90.1%	100 $1,000
Q4 2019 Jan 27, 2020	BUY	$1.51 - $2.27 $1,374 - $2,065	910 Added 910.0%	1,010 $2,000
Q3 2019 Sep 14, 2021	SELL	$1.59 - $2.51 $1,446 - $2,284	-910 Reduced 90.1%	100 $1,000
Q3 2019 Oct 22, 2019	BUY	$1.59 - $2.51 $1,446 - $2,284	910 Added 910.0%	1,010 $2,000
Q2 2019 Sep 14, 2021	SELL	$2.49 - $5.45 $522 - $1,144	-210 Reduced 67.74%	100 $1,000
Q2 2019 Jul 31, 2019	BUY	$2.49 - $5.45 $522 - $1,144	210 Added 210.0%	310 $1,000
Q1 2019 Sep 02, 2021	SELL	$1.47 - $5.91 $308 - $1,241	-210 Reduced 67.74%	100 $0
Q2 2018 Jul 31, 2018	BUY	$2.0 - $3.3 $620 - $1,023	310 New	310 $1,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $294M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.